The utility of fluorescence in situ hybridization (FISH) in the diagnosis of myxoid soft tissue neoplasms

American Journal of Surgical Pathology

Volumn 32, Issue 1, 2008, Pages 8-13

  Downs Kelly, Erinn ^a   Goldblum, John R ^a   Patel, Raj M ^a   Weiss, Sharon W ^b   Folpe, Andrew L ^c   Mertens, Fredrick ^d   Hartke, Marybeth ^a   Tubbs, Raymond R ^a   Skacel, Marek ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b EMORY UNIVERSITY   (United States)

^c MAYO CLINIC   (United States)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Extraskeletal myxoid chondrosarcoma; Fluorescence in situ hybridization; Low grade fibromyxoid sarcoma; Myxoid liposarcoma

Indexed keywords

ARTICLE; CHONDROSARCOMA; CHROMOSOME 12Q; CHROMOSOME 16P; CHROMOSOME 22Q; DDIT3 GENE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EWSR1 GENE; FLUORESCENCE IN SITU HYBRIDIZATION; FUS GENE; GENE; GENE REARRANGEMENT; GENOME; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERPHASE; MUSCLE TUMOR; MYXOID SOFT TISSUE TUMOR; MYXOMA; MYXOSARCOMA; SARCOMA; SOFT TISSUE TUMOR;

CALMODULIN-BINDING PROTEINS; DIAGNOSIS, DIFFERENTIAL; GENE REARRANGEMENT; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEIOMYOSARCOMA; LIPOSARCOMA, MYXOID; MYXOMA; RNA-BINDING PROTEIN FUS; RNA-BINDING PROTEINS; SOFT TISSUE NEOPLASMS; TRANSCRIPTION FACTOR CHOP;

EID: 37549059599     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181578d5a     Document Type: Article

References (28)

1. Aman P, Ron D, Mandahl N, et al. Rearrangement of the transcription factor gene DDIT3 in myxoid liposarcomas with t(12;16)(q13;p11). Genes Chromosomes Cancer. 1992;5:278-285.
2. Antonescu CR, Elahi A, Healey JH, et al. Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-DDIT3 or EWSR1-DDIT3 rearrangements. Clin Cancer Res. 2000;6:2788-2793.
3. Antonescu CR, Elahi A, Humphrey M, et al. Specificity of TLSDDIT3 rearrangement for classic myxoid/round cell liposarcoma: absence in predominantly myxoid well-differentiated liposarcomas. J Mol Diagn. 2000;2:132-138.
4. Attwooll C, Tariq M, Harris M, et al. Identification of a novel fusion gene involving hTAFII68 and NR4A3 from a t(9;17) (q22;q11.2) translocation in an extraskeletal myxoid chondrosarcoma. Oncogene. 1999;18:7599-7601.
5. Bjerkehagen B, Dietrich C, Reed W, et al. Extraskeletal myxoid chondrosarcoma: multimodal diagnosis and identification of a new cytogenetic subgroup characterized by t(9;17)(q22;q11). Virchows Arch. 1999;435:524-530.
6. Clark J, Benjamin H, Gill S, et al. Fusion of the EWSR1 gene to NR4A3, a member of the steroid/thyroid receptor gene superfamily, in a human myxoid chondrosarcoma. Oncogene. 1996;12:229-235.
7. Crozat A, Aman P, Mandahl N, et al. Fusion of DDIT3 to a novel RNA-binding protein in human myxoid liposarcoma. Nature. 1993;363:640-644.
8. Dal Cin P, Sciot R, Panagopoulos I, et al. Additional evidence of a variant translocation t(12;22) with EWSR1/DDIT3 fusion in myxoid liposarcoma: clinicopathological features. J Pathol. 1997;182:437-441.
9. Enzinger FM, Shiraki M. Extraskeletal myxoid chondrosarcoma. An analysis of 34 cases. Hum Pathol. 1972;3:421-435.
10. Evans HL. Low-grade fibromyxoid sarcoma. A report of two metastasizing neoplasms having a deceptively benign appearance. Am J Clin Pathol. 1987;88:615-619.
11. Harris M, Coyne J, Tariq M, et al. Extraskeletal myxoid chondrosarcoma with neuroendocrine differentiation: a pathologic, cytogenetic, and molecular study of a case with a novel translocation t(9;17)(q22;q11.2). Am J Surg Pathol. 2000;24:1020-1026.
12. Hinrichs SH, Jaramillo MA, Gumerlock PH, et al. Myxoid chondrosarcoma with a translocation involving chromosomes 9 and 22. Cancer Genet Cytogenet. 1985;14:219-226.
13. Kilpatrick SE, Doyon J, Choong PF, et al. The clinicopathologic spectrum of myxoid and round cell liposarcoma. A study of 95 cases. Cancer. 1996;77:1450-1458.
14. Matsuyama A, Hisaoka M, Shimajiri S, et al. Molecular detection of FUS-CREB3L2 fusion transcripts in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens. Am J Surg Pathol. 2006; 30: 1077-1084.
15. Mertens F, Fletcher CDM, Antonescu CR, et al. Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene. Lab Invest. 2005;85:408-415.
16. Mitelman F, Johansson B, Mertens F. Mitelman Database of Chromosome Aberrations in Cancer 2006. Available at: http://cgap.nci.nih.gov/Chromosomes/ Mitelman.
17. Panagopoulos I, Hoglund M, Mertens F, et al. Fusion of the EWSR1 and DDIT3 genes in myxoid liposarcoma. Oncogene. 1996;12:489-494.
18. Panagopoulos I, Storlazzi CT, Fletcher CDM, et al. The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma. Genes Chromosomes Cancer. 2004;40:218-228.
19. Patel RM, Downs-Kelly E, Weiss SW, et al. Dual-color, break-apart fluorescence in situ hybridization for EWSR1 gene rearrangement distinguishes clear cell sarcoma of soft tissue from malignant melanoma. Mod Pathol. 2005;18:1585-1590.
20. Rabbitts TH, Forster A, Larson R, et al. Fusion of the dominant negative transcription regulator DDIT3 with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat Genet. 1993;4:175-180.
21. Reid R, de Silva MV, Paterson L, et al. Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes share a common t(7;16)(q34;p11) translocation. Am J Surg Pathol. 2003;27:1229-1236.
22. Sandberg AA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: liposarcoma. Cancer Genet Cytogenet. 2004;155:1-24.
23. Sjogren H, Meis-Kindblom J, Kindblom LG, et al. Fusion of the EWSR1-related gene TAF2N to TEC in extraskeletal myxoid chondrosarcoma. Cancer Res. 1999;59:5064-5067.
24. Sjogren H, Wedell B, Meis-Kindblom JM, et al. Fusion of the NH2-terminal domain of the basic helix-loop-helix protein TCF12 to TEC in extraskeletal myxoid chondrosarcoma with translocation t(9;15)(q22;q21). Cancer Res. 2000;60:6832-6835.
25. Storlazzi CT, Mertens F, Nascimento A, et al. Fusion of the FUS and BBF2H7 genes in low grade fibromyxoid sarcoma. Hum Mol Genet. 2003;12:2349-2358.
26. Tsuneyoshi M, Enjoji M, Iwasaki H, et al. Extraskeletal myxoid chondrosarcoma - a clinicopathologic and electron microscopic study. Acta Pathol Jpn. 1981;31:439-447.
27. Turc-Carel C, Dal Cin P, Sandberg AA. Nonrandom translocation in extraskeletal myxoid chondrosarcoma. Cancer Genet Cytogenet. 1987;26:377.
28. Weiss SW, Goldblum JR. Enzinger and Weiss's Soft Tissue Tumors. St Louis, MO: Mosby, Inc; 2001.